TD Waterhouse Canada’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87K Buy
900
+500
+125% +$1.7K ﹤0.01% 1986
2026
Q1
$677 Buy
+400
New +$868 ﹤0.01% 2133
2025
Q1
– Sell
-10
Closed -$31 – 1966
2024
Q4
$31 Sell
10
-2,990
-100% -$10.7K ﹤0.01% 1929
2024
Q3
$8.31K Hold
3,000
– – ﹤0.01% 1394
2024
Q2
$3.6K Sell
3,000
-1,693
-36% -$1.52K ﹤0.01% 1557
2024
Q1
$3.98K Buy
+4,693
New +$4.27K ﹤0.01% 1572

Other funds holding CLOV

TD Waterhouse Canada's CLOV Position: Q2 2026 in Review

TD Waterhouse Canada increased its Clover Health Investments (CLOV) stake by 125% in Q2 2026, buying an estimated $1.7K and bringing the position to 900 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

TD Waterhouse Canada first reported a position in CLOV in Q1 2024 and has held it in 6 quarters since. The position peaked at $8.31K in Q3 2024. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • TD Waterhouse Canada held 900 shares of Clover Health Investments worth $4.87K as of Q2 2026.
  • TD Waterhouse Canada bought 500 Clover Health Investments shares in Q2 2026, an estimated $1.7K.
  • Clover Health Investments made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1986 holding.
  • TD Waterhouse Canada first reported a position in Clover Health Investments in Q1 2024 and has held it in 6 quarters since.
  • TD Waterhouse Canada's Clover Health Investments position peaked at $8.31K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.